The RPS17 gene gives cells instructions for part of the ribosome, the cell’s protein making machinery. Every cell in your body uses this gene to build proteins needed for growth, blood cell production, and everyday repair. If the gene does not work properly, some people develop Diamond-Blackfan anemia, a condition in which the bone marrow makes too few red blood cells, often leading to tiredness, pale skin, and slower growth.
What is a gene?
A gene is a piece of DNA that holds instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for making proteins, the parts of cells that do much of the work. Other genes mainly guide when certain activities take place, where they happen, and how strongly they occur. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medicines. For a deeper look at this topic, you can find more in the LearnHub.
Overview
RPS17Gene function
What if the gene works
The RPS17 gene helps make ribosomes, the cell parts that build proteins. Its protein is part of the small ribosome unit, supporting normal growth and everyday cell function.
Risk
What if the gene does not work
Variants in the RPS17 gene can cause Diamond-Blackfan anemia, often leading to low red blood cell production, tiredness, and pale skin. Milder to more severe variants may influence when problems begin and whether growth or birth differences also appear.
Treatment
What does that mean for your treatment
No RPS17-specific treatment or drug choice is currently established for pathogenic variants in the RPS17 gene. Management usually follows the standard treatment plan for the diagnosed condition, rather than a therapy selected specifically because of RPS17.
Conditions associated with RPS17
Gene function
What if the gene works
Every day, your cells need proteins to grow, repair, and keep organs working. Across many tissues, the RPS17 gene contributes to steady, routine cell activity. It does this by helping form ribosomes, the cell structures that read genetic instructions and build proteins.
The RPS17 gene provides one of the building blocks of the small ribosome subunit. This helps cells assemble ribosomes with the right shape for routine protein production.
Inside ribosomes, its protein helps the small subunit handle messenger RNA (a working copy of genetic instructions). This supports the step where cells read those instructions in order to make proteins.
By supporting ribosome function, the RPS17 gene helps cells keep a steady flow of proteins for growth, repair, and daily maintenance. This is part of how cells make proteins throughout the body.
What is a variant?
A genetic variant is a minor difference in a gene’s DNA sequence. Variants are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body reacts to environmental influences. Many do not have any noticeable effect and are simply part of natural genetic variation. At times, though, a variant changes how a gene works more significantly and can contribute to, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
Most variants in the RPS17 gene reduce the amount of working RPS17 protein rather than changing its structure. This helps explain how variants in the RPS17 gene affect ribosome production, because cells may struggle to build ribosomes, the protein making structures inside the cell. Milder variants may leave some activity in place, while more severe variants can cause a bigger drop in ribosome function. In Diamond-Blackfan anemia, that difference can influence how early and how strongly features appear.
How variants are linked to conditions
Pathogenic variants in the RPS17 gene can cause Diamond-Blackfan anemia, a rare inherited condition that often appears in infancy with low red blood cell counts. In many families, RPS17 gene variants linked to Diamond-Blackfan anemia help confirm the diagnosis when anemia occurs with poor growth or certain physical differences. Some people with an RPS17-related diagnosis have milder features than others.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors also play a role. In some situations, however, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the RPS17 gene. For many living with a harmful RPS17 change, risk is mainly linked to the variant itself rather than lifestyle, so care usually focuses on monitoring, early detection, and managing health problems if they appear.
Inheritance of RPS17 variants
Variants in the RPS17 gene are inherited in an autosomal dominant pattern for RPS17-related Diamond-Blackfan anemia. This means a child can inherit the condition if just one parent carries a disease-causing variant, and each child of that parent has a 50% chance of inheriting it. Some people have a new, de novo variant in the RPS17 gene, which means it started in them and was not inherited from either parent. In practical terms, the RPS17 inheritance pattern can involve an affected parent passing it to a son or daughter, or a child being the first person in the family to have the variant.
What does my RPS17 result mean for my family?
A disease-causing RPS17 result is usually linked to a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same change. This can matter even within one family, because some people have clear symptoms while others have milder findings or none that are obvious. Some RPS17 changes happen for the first time in one person, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the RPS17 gene, a lab can study DNA from a blood sample or cheek swab. RPS17 genetic testing usually uses sequencing to look for spelling changes, and some tests also check for missing or extra pieces of the gene.
When should I consider getting a genetic test?
Consider RPS17 testing if you or your child has severe anemia, meaning too few red blood cells, starting in infancy or early childhood, especially with a family history of Diamond-Blackfan anemia. Testing may help confirm whether a change in this gene is the cause and can clarify risks for relatives.
A genetic result is only one part of your health story
A genetic result can be informative, but what it can tell you varies with the condition and the specific variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also shape how the body functions. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic differences can influence how your body responds to certain medicines. They can affect how a drug is processed, how strongly it works, or how sensitive you are to side effects. This is one reason the same treatment may help one person more than another, even when they take the same medication in the same way.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medications. It studies gene and drug patterns to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence either how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more individualized. To look into this subject further, you can learn more in the LearnHub.
Drugs influenced by the RPS17 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how medicines are chosen or used, so any health concerns or questions about medicines are best discussed with your doctor.
History
The RPS17 gene entered medical genetics through research on Diamond-Blackfan anemia, a rare inherited condition first described in the 1930s. Decades later, scientists began linking some cases of this condition to changes in genes that make parts of the ribosome, the cell’s protein-making machinery. From these first observations, research expanded steadily, and the RPS17 gene became one of the ribosomal protein genes connected to Diamond-Blackfan anemia. This helped shift thinking about the condition from a blood disorder defined only by symptoms to one with a clearer genetic basis. Over time, descriptions became more precise as genetic testing made it easier to identify people carrying RPS17 variants. Today, the RPS17 gene is part of the broader story of how rare inherited anemias helped reveal important pathways in human genetics.